Related Experiment Videos
Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression
Sandy Chang1, Christine M Khoo, Maria L Naylor
1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA.
Genes & Development
|January 7, 2003
Summary
Telomere dysfunction drives cancer genome evolution and chromosomal aberrations. However, telomerase activation is crucial for enabling initiated cancer cells to metastasize effectively.
Area of Science:
- Oncology
- Genetics
- Cell Biology
Background:
- Telomerase activation is common in advanced cancers, potentially restoring genomic stability for tumor progression.
- Telomere dysfunction and crisis are linked to genomic instability and cancer development.
Purpose of the Study:
- To investigate the relationship between telomere crisis, genome evolution, and tumor biology using genetically defined mouse models.
- To differentiate the roles of telomerase-dependent and independent telomere maintenance in cancer progression and metastasis.
Main Methods:
- Utilized genetically engineered mouse embryonic fibroblast (MEF) cultures from mTerc(-/-) Ink4a/Arf(-/-) mice.
- Performed serial cytogenetic analysis and extensive cell culture passage.
- Assessed tumor formation and metastatic potential in immunocompromised mice.
- Investigated telomerase-independent alternative lengthening of telomeres (ALT).
Main Results:
- Telomere dysfunction induced chromosomal fusions, deletions, and translocations.
- Transformed cells with telomere dysfunction formed tumors but lacked metastatic capacity.
- Telomerase reconstitution restored metastatic potential.
- Alternative Lengthening of Telomeres (ALT) was observed in vivo, but ALT+ tumors did not metastasize.
Conclusions:
- Telomere dysfunction initiates carcinogenesis by causing genomic instability.
- Telomerase-mediated telomere maintenance is essential for malignant progression and metastasis.
- Distinct telomere maintenance mechanisms (telomerase vs. ALT) have different functional outcomes in vivo, particularly regarding metastasis.